Job offers

Company

Job offers

We are a medium-sized company in the field of machinery and plant engineering, known nationally and internationally for our quality products.

Our future-oriented solutions involve developing and producing special machinery, apparatus, tanks, automation, cleaning and volume measurement systems for the pharmaceutical, chemical and food processing industries as well as public contractors, and forms the basis for continuous growth.

We are looking for the following person to start as soon as possible to strengthen our team:

Maintenance employee/ mechatronics technician/ metal worker/ construction mechanic at the Ilmenau site
Welder/tank builder
Design engineer Special Purpose Machinery
Apprenticeship as a plant mechanic for apparatus and tank construction (m/f/d)

Company

Contact

Please send your application to:

personal@edelstahlbau.de
oder an
Edelstahlbau Tannroda GmbH
Managing Director
Bad Berkaer Str. 10
99438 Bad Berka

Company

portfolio

links

Dear Sir or Madam,
Dear Mr Weinert,
27.04.2021


On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.


Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE